Minimal change disease and focal segmental glomerulosclerosis

被引:0
|
作者
Osterholt, Thomas [1 ]
Benzing, Thomas [1 ]
Brinkkoetter, Paul Thomas [1 ]
机构
[1] Uniklin Koln, Klin Innere Med Nephrol Rheumatol Diabetol & Allge, Kerpener Str 62, D-50937 Cologne, Germany
来源
NEPHROLOGIE | 2025年 / 20卷 / 01期
关键词
FSGS; MCD; Minimal change disease; Focal segmental glomerulosclerosis; Review; CONGENITAL NEPHROTIC SYNDROME; FINNISH TYPE; ADULTS; FSGS;
D O I
10.1007/s11560-024-00814-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are among the most common causes of nephrotic syndrome. Histologically both diseases are defined as podocytopathies characterized by the fusion of podocyte foot processes which are visible under electron microscopy. While the exact pathogenesis was unclear for a long time, accumulating evidence suggests that anti-nephrin antibodies play a central role in many cases of MCD. The genesis of FSGS is complex. The disease is characterized by the irreversible loss of podocytes and a resulting focal sclerosis in the glomerulus. The differentiation between primary, secondary and genetic forms of these diseases is crucial for the selection of treatment as only primary forms generally require immunosuppression. Several therapeutic approaches are available for treatment, including steroids, calcineurin inhibitors (CNI), such as tacrolimus and mycophenolate mofetil (MMF). The FSGS and MCD differ in their response rates to treatment, with FSGS generally having a poorer prognosis. In the future, targeted therapies will gain increasing importance, especially in genetically related variants of FSGS. Overall, the treatment of MCD and FSGS remains a challenge and requires a customized and carefully coordinated treatment based on individual patient characteristics.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 50 条
  • [41] Significance of C4d expression in minimal change disease and focal segmental glomerulosclerosis
    Son, Min Jeong
    Park, Jeong Hwan
    Kim, Dong Ki
    Joo, Kwon Wook
    Kim, Sung Gwon
    Hwang, Young Hwan
    Moon, Kyung Chul
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 8215 - 8222
  • [42] Minimal-Change-Disease (MCD) und fokal-segmentale GlomeruloskleroseMinimal change disease and focal segmental glomerulosclerosis
    Thomas Osterholt
    Thomas Benzing
    Paul Thomas Brinkkötter
    Die Nephrologie, 2025, 20 (1) : 18 - 25
  • [43] Podocyte mRNA in the urinary sediment of minimal change nephropathy and focal segmental glomerulosclerosis
    Szeto, Cheuk-Chun
    Wang, Gang
    Chow, Kai-Ming
    Lai, Fernand Mac-Moune
    Ma, Terry King-Wing
    Kwan, Bonnie Ching-Ha
    Luk, Cathy Choi-Wan
    Li, Philip Kam-Tao
    CLINICAL NEPHROLOGY, 2015, 84 (04) : 198 - 205
  • [44] HLA IN MINIMAL CHANGE NEPHROTIC SYNDROME(MC) AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS(FSS)
    LENHARD, V
    MULLERWIEFEL, DE
    DIPPELL, J
    SCHRODER, D
    SEIDL, S
    SCHARER, K
    PEDIATRIC RESEARCH, 1980, 14 (08) : 1003 - 1003
  • [45] GLOMERULAR ANIONIC SITES IN MINIMAL CHANGE NEPHROTIC SYNDROME AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS
    KITANO, Y
    YOSHIKAWA, N
    NAKAMURA, H
    CLINICAL NEPHROLOGY, 1993, 40 (04) : 199 - 204
  • [46] Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis
    Regele, HM
    Fillipovic, E
    Langer, B
    Poczewki, H
    Kraxberger, I
    Bittner, RE
    Kerjaschki, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (03): : 403 - 412
  • [47] Up to date of pathophysiology mechanism of idiopathic nephrotic syndromes: Minimal change disease and focal and segmental glomerulosclerosis
    De La Roque, Charlotte Dumas
    Combe, Christian
    Rigothier, Claire
    NEPHROLOGIE & THERAPEUTIQUE, 2018, 14 (07): : 501 - 506
  • [48] Podocyte EGR1 Expression in Patients with Primary Focal Segmental Glomerulosclerosis and Minimal Change Disease
    Okabe, Masahiro
    Koike, Kentaro
    Tsuboi, Nobuo
    Matsusaka, Taiji
    Yokoo, Takashi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [49] Glomerular tip lesion: A distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum
    Stokes, MB
    Markowitz, GS
    Lin, J
    Valeri, AM
    D'Agati, VD
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1690 - 1702
  • [50] CD80 and suPAR: Diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?
    Jean-Claude Davin
    Pediatric Nephrology, 2014, 29 : 1465 - 1466